Steve Schonfeld’s Organogenesis Holdings ORGO Stock Holding History

Steve Schonfeld’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.6K	Buy	+25,747	New	+$62.9K	﹤0.01%	2357
2023 Q3	–	Sell	-17,000	Closed	-$56.4K	–	2152
2023 Q2	$56.4K	Buy	+17,000	New	+$50.2K	﹤0.01%	1801
2022 Q2	–	Sell	-78,316	Closed	-$597K	–	2873
2022 Q1	$597K	Buy	+78,316	New	+$606K	0.01%	1260
2021 Q1	–	Sell	-137,700	Closed	-$1.04M	–	2042
2020 Q4	$1.04M	Buy	+137,700	New	+$654K	0.01%	802

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Steve Schonfeld's ORGO Position: Q2 2026 in Review

Steve Schonfeld opened a new position in Organogenesis Holdings (ORGO) in Q2 2026: 25,747 shares worth $62.6K. The stake represents ﹤0.01% of the portfolio and ranks #2357 among its holdings. This is a return to the name: Steve Schonfeld previously reported a position in ORGO as recently as Q2 2023.

Steve Schonfeld first reported a position in ORGO in Q4 2020 and has held it in 4 quarters since. The position peaked at $1.04M in Q4 2020. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Steve Schonfeld held 25,747 shares of Organogenesis Holdings worth $62.6K as of Q2 2026.
Organogenesis Holdings was a new Steve Schonfeld position in Q2 2026.
Organogenesis Holdings made up ﹤0.01% of Steve Schonfeld's portfolio in Q2 2026, its #2357 holding.
Steve Schonfeld first reported a position in Organogenesis Holdings in Q4 2020 and has held it in 4 quarters since.
Steve Schonfeld's Organogenesis Holdings position peaked at $1.04M in Q4 2020.
134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.